Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.Journal of psychoactive drugs · 2025-01-01Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.Nature. Mental health · 2024-11-01Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-07-01Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-07-01Impact of Psilocybin on Peripheral Cytokine Production.Psychedelic medicine (New Rochelle, N.Y.) · 2024-06-01The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.PloS one · 2024-01-01Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.Journal of psychoactive drugs · 2024-01-01Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.Psychedelic medicine (New Rochelle, N.Y.) · 2023-12-01Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.Psychiatry research · 2023-09-01Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434.NeuroImage · 2023-07-01Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.Journal of psychopharmacology (Oxford, England) · 2023-07-01Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.Frontiers in psychiatry · 2023-01-01Psychedelic-Assisted Therapy for People with Eating Disorders.Current psychiatry reports · 2022-12-01Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Neuropharmacology · 2022-11-01Serotonergic antidepressant use is associated with weaker psilocybin effectsPsyArXiv · 2022-10-28Serotonergic antidepressant use is associated with weaker psilocybin effectsPsyArXiv · 2022-10-28Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.NeuroImage · 2022-10-15Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and MetamemorybioRxiv · 2022-05-24Models of psychedelic drug action: modulation of cortical-subcortical circuits.Brain: a journal of neurology · 2022-04-18Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivitybioRxiv · 2022-03-02Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of psychopharmacology (Oxford, England) · 2022-02-01The Potential of Psychedelics for End of Life and Palliative Care.Current topics in behavioral neurosciences · 2022-01-01Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.PloS one · 2022-01-01Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational psychiatry · 2021-11-08Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-09-01Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.The international journal of neuropsychopharmacology · 2021-08-20Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2021-05-01Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.JAMA psychiatry · 2021-05-01Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.Journal of psychopharmacology (Oxford, England) · 2021-04-01Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.Journal of psychopharmacology (Oxford, England) · 2021-04-01Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reportsPsyArXiv · 2021-02-24Trends in the Top-Cited Articles on Classic Psychedelics.Journal of psychoactive drugs · 2021-01-01Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Frontiers in neuroergonomics · 2021-01-01Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.NeuroImage · 2020-09-01Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.Psychopharmacology · 2020-08-01Emotions and brain function are altered up to one month after a single high dose of psilocybin.Scientific reports · 2020-02-10Cessation and reduction in alcohol consumption and misuse after psychedelic use.Journal of psychopharmacology (Oxford, England) · 2019-09-01Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.Pharmacology & therapeutics · 2019-05-01Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.PloS one · 2019-01-01Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.Frontiers in psychiatry · 2019-01-01The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.Neuropharmacology · 2018-11-01Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.Psychopharmacology · 2018-10-01Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.Journal of psychopharmacology (Oxford, England) · 2018-07-01T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking SmokersBiological Psychiatry · 2018-04-08Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.Psychopharmacology · 2018-02-01Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.Current topics in behavioral neurosciences · 2018-01-01Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of psychopharmacology (Oxford, England) · 2018-01-01Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in psychology · 2018-01-01Neuroticism is associated with challenging experiences with psilocybin mushrooms.Personality and individual differences · 2017-10-15An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.Journal of psychopharmacology (Oxford, England) · 2017-07-01Potential Therapeutic Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2017-07-01Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settingsDrug and Alcohol Dependence · 2017-01-21Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experienceDrug and Alcohol Dependence · 2017-01-21Long-term follow-up of psilocybin-facilitated smoking cessation.The American journal of drug and alcohol abuse · 2017-01-01Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.Frontiers in psychology · 2017-01-01Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of psychopharmacology (Oxford, England) · 2016-12-01The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Journal of psychopharmacology (Oxford, England) · 2016-12-01Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Journal of psychopharmacology (Oxford, England) · 2016-12-01Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The international journal of neuropsychopharmacology · 2016-07-01Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accountsDrug and Alcohol Dependence · 2015-11-01Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybinDrug and Alcohol Dependence · 2015-11-01Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.Journal of psychopharmacology (Oxford, England) · 2015-11-01Comparative phenomenology of psilocybin experiences in research and non-research settingsDrug and Alcohol Dependence · 2015-10-31Psilocybin, psychological distress, and suicidality.Journal of psychopharmacology (Oxford, England) · 2015-09-01Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-16The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-16Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.Journal of psychopharmacology (Oxford, England) · 2014-11-01Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybinDrug and Alcohol Dependence · 2014-06-07Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot studyDrug and Alcohol Dependence · 2014-06-07PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A 2014 REPORTCouncil on Spiritual Practices · 2014-01-01Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.Current drug abuse reviews · 2014-01-01Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.Journal for the scientific study of religion · 2012-12-01High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.Psychopharmacology · 2012-09-01Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.Drug and alcohol dependence · 2012-06-01Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.Psychopharmacology · 2011-12-01Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.Journal of psychopharmacology (Oxford, England) · 2011-11-01Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.Journal of psychopharmacology (Oxford, England) · 2008-08-01Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.Psychopharmacology · 2006-08-01